Floatz logo

Esmolol

Hemorrhagic Stroke

Cristália Produtos Químicos Farmacêuticos Ltda.Small moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Hemorrhagic Stroke cohort.

View all 25

Same molecule, other indications

Esmolol is also rated in:

Intraoperative AwarenessDormant
BB
Indicative ·
65 / 100
View asset →
post-operative pain, non-human animalDormant
B
Indicative ·
62 / 100
View asset →
diabetes mellitusDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →